Seagen Shares Owned by Institutions

SGEN
 Stock
  

USD 135.27  3.93  2.82%   

Seagen Inc fundamentals help investors to digest information that contributes to Seagen's financial success or failures. It also enables traders to predict the movement of Seagen Stock. The fundamental analysis module provides a way to measure Seagen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Seagen stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  

Seagen Shares Owned by Institutions Analysis

Seagen's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Shares Held by Institutions 
 = 
Funds and Banks 
Firms 
More About Shares Owned by Institutions | All Equity Analysis

Current Seagen Shares Owned by Institutions

    
  93.22 %  
Most of Seagen's fundamental indicators, such as Shares Owned by Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Seagen Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Compare to competition

Based on the latest financial disclosure, 93% of Seagen Inc are shares owned by institutions. This is 108.83% higher than that of the Healthcare sector and 96.25% higher than that of the Biotechnology industry. The shares owned by institutions for all United States stocks is 137.75% lower than that of the firm.

Seagen Institutional Holders

Institutional Holdings refers to the ownership stake in Seagen that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Seagen's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Seagen's value.
Security TypeSharesValue
Baker Bros Advisors LpCommon Shares46.9 M8.3 B
Capital International InvestorsCommon Shares15.5 M2.7 B
Vanguard Group IncCommon Shares12.5 M2.2 B
Blackrock IncCommon Shares11.4 MB
Wellington Management Group LlpCommon Shares8.7 M1.5 B
Primecap Management CoCommon Shares4.6 M811.9 M
Capital World InvestorsCommon Shares3.5 M627.3 M

Seagen Fundamentals

About Seagen Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Seagen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Seagen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Seagen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. It also develops TIVDAK for metastatic cervical cancer and other solid tumors Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors Disitamab Vedotin, a novel HER2-targeted ADC and SEA-CD40, SEA-TGT, SEA-BCMA, and SEA-CD70 for various cancer diseases. Seagen Inc. has collaboration agreements with Takeda Pharmaceutical Company Limited Agensys, Inc. Genmab AS Merck and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Seagen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module

Currently Active Assets on Macroaxis

Additionally, take a look at Seagen Piotroski F Score and Seagen Altman Z Score analysis. Note that the Seagen Inc information on this page should be used as a complementary analysis to other Seagen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Seagen Stock analysis

When running Seagen Inc price analysis, check to measure Seagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seagen is operating at the current time. Most of Seagen's value examination focuses on studying past and present price action to predict the probability of Seagen's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Seagen's price. Additionally, you may evaluate how the addition of Seagen to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Is Seagen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Seagen. If investors know Seagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Seagen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Seagen Inc is measured differently than its book value, which is the value of Seagen that is recorded on the company's balance sheet. Investors also form their own opinion of Seagen's value that differs from its market value or its book value, called intrinsic value, which is Seagen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Seagen's market value can be influenced by many factors that don't directly affect Seagen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Seagen's value and its price as these two are different measures arrived at by different means. Investors typically determine Seagen value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Seagen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.